Market Blog

Sentiments dictate BioMarin and Salesforce.com

BMRN– BioMarin Pharmaceutical Inc evelops and commercializes pharmaceuticals for various diseases and medical conditions. BMRN– BioMarin Pharmaceutical Inc Fundamentals Previously closed at 89.65 Day's high 91.26 Day's low 88.94 P/E ratio NA EPS -1.18   Analysts opinion BioMarin is a specialist in rare-disease specialist. The controversial drug Kyndrisa, which intended to treat Duchenne muscular dystrophy was rejected by the Committee for Medical Products for Human Use (CHMP). Analyst confidence meter,
Market Blog

The plunging ‘Cloud’ – Palo Alto and Salesforce may have further bearish sentiments

Palo Alto Networks, Inc., a cloud-based internet security company fell as much as 15% on Friday despite a lack of any kind of news. We saw a free fall of cloud-based tech stocks on Friday, despite positive earnings reports and "Buy" recommendations from brokers. PANW - Palo Alto Networks, Inc Fundamentals Previously closed at 127.51 Days high 139.89 Days low 123.8 P/E ratio N/A EPS -2.09   Analyst opinion Despite